US4201210A
(en)
*
|
1976-06-22 |
1980-05-06 |
The United States Of America As Represented By The Secretary Of Agriculture |
Veterinary ocular ring device for sustained drug release
|
US4223022A
(en)
*
|
1978-01-16 |
1980-09-16 |
Schering Corporation |
Stabilized aminoglycoside antibiotic formulations
|
US4298002A
(en)
*
|
1979-09-10 |
1981-11-03 |
National Patent Development Corporation |
Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation
|
US4281654A
(en)
*
|
1980-04-07 |
1981-08-04 |
Alza Corporation |
Drug delivery system for controlled ocular therapy
|
US4484922A
(en)
*
|
1981-06-25 |
1984-11-27 |
Rosenwald Peter L |
Occular device
|
US4678466A
(en)
*
|
1981-06-25 |
1987-07-07 |
Rosenwald Peter L |
Internal medication delivery method and vehicle
|
US4653483A
(en)
*
|
1982-11-12 |
1987-03-31 |
Clavin Harold D |
Cosmetic tape, applicator therefor and method
|
US4524776A
(en)
*
|
1983-10-27 |
1985-06-25 |
Withers Stanley J |
Split carrier for eyelid sensor and the like
|
US5147647A
(en)
*
|
1986-10-02 |
1992-09-15 |
Sohrab Darougar |
Ocular insert for the fornix
|
US5322691A
(en)
*
|
1986-10-02 |
1994-06-21 |
Sohrab Darougar |
Ocular insert with anchoring protrusions
|
US5989579A
(en)
*
|
1986-10-02 |
1999-11-23 |
Escalon Medical Corp. |
Ocular insert with anchoring protrusions
|
US5098443A
(en)
*
|
1989-03-23 |
1992-03-24 |
University Of Miami |
Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
|
US5660851A
(en)
*
|
1989-12-26 |
1997-08-26 |
Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem |
Ocular inserts
|
US5384333A
(en)
*
|
1992-03-17 |
1995-01-24 |
University Of Miami |
Biodegradable injectable drug delivery polymer
|
US5178635A
(en)
*
|
1992-05-04 |
1993-01-12 |
Allergan, Inc. |
Method for determining amount of medication in an implantable device
|
US5314419A
(en)
*
|
1992-10-30 |
1994-05-24 |
Pelling George E |
Method for dispensing ophthalmic drugs to the eye
|
US5433714A
(en)
*
|
1993-04-06 |
1995-07-18 |
Bloomberg; Leroy |
Topical anesthesia method for eye surgery, and applicator therefor
|
US5618274A
(en)
*
|
1994-04-08 |
1997-04-08 |
Rosenthal; Kenneth J. |
Method and device for deep pressurized topical, fornix applied "nerve block" anesthesia
|
US5466233A
(en)
*
|
1994-04-25 |
1995-11-14 |
Escalon Ophthalmics, Inc. |
Tack for intraocular drug delivery and method for inserting and removing same
|
US5472436A
(en)
*
|
1994-07-26 |
1995-12-05 |
Fremstad; Daria A. |
Ocular appliance for delivering medication
|
US5601548A
(en)
*
|
1994-11-07 |
1997-02-11 |
Ophthalmic International, L.L.C. |
Open angle glaucoma treatment apparatus and method
|
US5641750A
(en)
*
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
|
US5641749A
(en)
*
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
|
US6013122A
(en)
|
1998-08-18 |
2000-01-11 |
Option Technologies, Inc. |
Tattoo inks
|
WO2002100318A2
(en)
|
2001-06-12 |
2002-12-19 |
Johns Hopkins University School Of Medicine |
Reservoir device for intraocular drug delivery
|
US7031776B2
(en)
*
|
2001-06-29 |
2006-04-18 |
Optobionics |
Methods for improving damaged retinal cell function
|
US20050004625A1
(en)
*
|
2001-06-29 |
2005-01-06 |
Chow Alan Y. |
Treatment of degenerative retinal disease via electrical stimulation of surface structures
|
US20050033202A1
(en)
|
2001-06-29 |
2005-02-10 |
Chow Alan Y. |
Mechanically activated objects for treatment of degenerative retinal disease
|
JP2005507866A
(en)
*
|
2001-08-07 |
2005-03-24 |
ヴィスタ サイエンティフィック エルエルシー |
Drug release system for management therapy
|
EP1283025A1
(en)
*
|
2001-08-10 |
2003-02-12 |
Stöckert Instrumente GmbH |
Ballon occlusion device
|
US7073507B2
(en)
*
|
2001-11-05 |
2006-07-11 |
David Morris |
Sterile ocular cover and method
|
WO2005023181A2
(en)
*
|
2003-08-22 |
2005-03-17 |
Vista Scientific |
Polymeric systems for controlled drug therapy
|
US8167855B2
(en)
*
|
2003-08-26 |
2012-05-01 |
Vista Scientific Llc |
Ocular drug delivery device
|
EP1929304A2
(en)
*
|
2005-08-19 |
2008-06-11 |
Freedom-2, LLC |
Cellular or organelle-entrapped nanoparticles
|
US20080188416A1
(en)
*
|
2007-02-05 |
2008-08-07 |
Freedom-2, Inc. |
Tissue fillers and methods of using the same
|
US9125807B2
(en)
|
2007-07-09 |
2015-09-08 |
Incept Llc |
Adhesive hydrogels for ophthalmic drug delivery
|
US10398594B2
(en)
|
2007-10-04 |
2019-09-03 |
Aciont, Inc. |
Intrascleral drug delivery device and associated methods
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
SG173167A1
(en)
|
2009-01-29 |
2011-08-29 |
Forsight Labs Llc |
Posterior segment drug delivery
|
JP5695035B2
(en)
*
|
2009-06-03 |
2015-04-01 |
フォーサイト・ビジョン5・インコーポレイテッドForsight Vision5,Inc. |
Anterior eye drug supply
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
EP2600930B1
(en)
|
2010-08-05 |
2021-02-17 |
ForSight Vision4, Inc. |
Injector apparatus for drug delivery
|
JP5907966B2
(en)
|
2010-08-05 |
2016-04-26 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
Implantable therapy device
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
JP2014518270A
(en)
|
2011-06-27 |
2014-07-28 |
ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム |
Toroidal pharmaceutical formulation
|
EP4249059A3
(en)
|
2011-06-28 |
2023-11-29 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
US9102105B2
(en)
|
2011-09-13 |
2015-08-11 |
Vista Scientific Llc |
Method for forming an ocular drug delivery device
|
AU2012308317B2
(en)
|
2011-09-14 |
2017-01-05 |
Forsight Vision5, Inc. |
Ocular insert apparatus and methods
|
CA2848385C
(en)
|
2011-09-16 |
2021-10-26 |
Forsight Vision4, Inc. |
Methods and apparatus to exchange a fluid of an implantable device
|
JP5852449B2
(en)
*
|
2012-01-20 |
2016-02-03 |
原 裕 |
Conjunctival sac fitting
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
HUE046128T2
(en)
|
2012-10-26 |
2020-02-28 |
Forsight Vision5 Inc |
Ophthalmic system for sustained release of drug to eye
|
US9968603B2
(en)
|
2013-03-14 |
2018-05-15 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
EP4302736A3
(en)
|
2013-03-28 |
2024-04-03 |
ForSight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
WO2015066616A1
(en)
*
|
2013-11-04 |
2015-05-07 |
Thompson Vance M |
Conjunctival cover and methods therefor
|
US9668916B2
(en)
|
2013-11-04 |
2017-06-06 |
Vance M. Thompson |
Conjunctival cover and methods therefor
|
KR102416726B1
(en)
|
2014-07-15 |
2022-07-05 |
포사이트 비젼4, 인크. |
Ocular implant delivery device and method
|
JP2017524034A
(en)
|
2014-08-08 |
2017-08-24 |
フォーサイト・ビジョン フォー・インコーポレーテッドForsight Vision4, Inc. |
Stable and soluble formulations of receptor tyrosine kinase inhibitors and methods for their preparation
|
WO2016031093A1
(en)
*
|
2014-08-28 |
2016-03-03 |
株式会社ユニバーサルビュー |
Ocular insert device
|
JP5671183B1
(en)
*
|
2014-08-28 |
2015-02-18 |
株式会社ユニバーサルビュー |
Eyelid interior tools
|
JP5643461B1
(en)
*
|
2014-08-28 |
2014-12-17 |
株式会社ユニバーサルビュー |
Eyelid interior tools
|
JP5643460B1
(en)
*
|
2014-08-28 |
2014-12-17 |
株式会社ユニバーサルビュー |
Eyelid interior tools
|
AU2015346450B2
(en)
|
2014-11-10 |
2020-01-30 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and method of use
|
TW201642914A
(en)
*
|
2015-02-23 |
2016-12-16 |
組織科技股份有限公司 |
Apparatuses and methods for treating ophthalmic diseases and disorders
|
US9869883B2
(en)
|
2015-03-11 |
2018-01-16 |
Vance M. Thompson |
Tear shaping for refractive correction
|
US20160296532A1
(en)
|
2015-04-13 |
2016-10-13 |
Forsight Vision5, Inc. |
Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
|
US10010502B2
(en)
|
2015-05-19 |
2018-07-03 |
Amorphex Therapeutics Llc |
Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
|
CA3005238A1
(en)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
BR112018070383A2
(en)
|
2016-04-05 |
2019-02-05 |
Forsight Vision4 Inc |
implantable ocular drug delivery devices
|
US10353220B2
(en)
|
2016-10-17 |
2019-07-16 |
Vance M. Thompson |
Tear shaping for refractive correction
|
CN107224348B
(en)
*
|
2017-06-01 |
2020-05-05 |
佛山勃林格医疗器械有限公司 |
Eye surface sustained-release drug delivery device and manufacturing method thereof
|
CA3082891A1
(en)
|
2017-11-21 |
2019-05-31 |
Forsight Vision4, Inc. |
Fluid exchange apparatus for expandable port delivery system and methods of use
|
US10678067B2
(en)
|
2018-04-06 |
2020-06-09 |
Vance M. Thompson |
Tear shaping for refractive correction
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|